Company Profile
Biotech International Ltd specialises identifying and formulating specific chemical compounds to create powder and liquid-based healthcare formulations. Each formulation is specific for a particular application. The ultimate task for Biotech products is to eliminate most pathogens; the formulations have also been designed to be active and to inhibit the relevant target bacteria in specific consumer and industrial applications.
The company is a wholly-owned subsidiary of Biocide International PLC.
Biotech’s additional technical support and data comes from access to well known manufacturers of chemicals such as Lonza GmbH, who distribute products globally, and testing companies such as Evans Vanodine International plc. This support enables the Company to operate within the Government Health & Safety Regulations and in line with the Biocide Products Directive (BPD); all the chemical constituents are registered with the authorities administering the BPD.
The products have also been scrutinised by UKAS and NAMAS (accredited microbiology testing laboratories). This is part of Biotech’s testing programme which allows the adoption of new techniques and assists in the development of the Company’s next-generation products.
Biotech International Ltd also produce Mozzi-Mort™, a clear water-based
coating that eradicates insects such as mosquitoes. 
Details can be found at www.mozzi-mort.com
Scientific Advisory Board
The Company has set up a Scientific Advisory Board, the key role of which is to oversee scientific and future formulation and product development direction.
The Board comprises:
• Chairman – Professor the Lord Ian McColl, currently Shadow Minister for Health. He studied medicine at London University and was Professor of Surgery at Guy's Hospital until 1998 and continues to teach at King's College on the Guy's Campus. He is Chairman of Mercyships UK, Vice-President of the Mildmay Centres of Palliative Care in London and Uganda, President of the Leprosy Mission and Vice-President of the Prince of Wales Health Council on Disability.
• Professor Nadey Hakim, ex-President of the International College of Surgeons; Consultant General Surgeon at Cromwell Hospital; Surgical Director Transplant Unit - Hammersmith Hospital. He performed the first arm transplant and the first double arm transplant in the world. Prof. Hakim is the author of over 100 articles and has written/edited 10 textbooks.
• Dr Mahmoud Barbir, Consultant Cardiologist at the Royal Brompton and Harefield Hospital.
• Dr. Nigel Hill is Medical Entomologist and Vector Biologist in the Disease Control & Vector Biology Unit at the London School of Hygiene & Tropical Medicine. Areas of research include the status of insecticide resistance in UK head louse populations, the effects of sub-lethal doses of insecticides on malaria vector mosquitoes, and house dust mite interventions for reducing sensitisation & severity of atopic allergies such as asthma & eczema.
• Microbiologist – to be appointed
• Virologist – to be appointed
At present, Board membership is unpaid and honorary.